Insulin receptor substrate-2 (989-1007)

Insulin receptor substrate 2

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: ta-161

Synonyms/Alias:Insulin receptor substrate-2 (989-1007)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Sequence
PKPGAPSGHPVGSLDGLLS
Areas of Interest
Antigen-presenting Cells; Cancer Research

Insulin receptor substrate-2 (989-1007) is a synthetic peptide fragment corresponding to amino acids 989 through 1007 of the IRS-2 protein, a critical adaptor molecule in insulin and insulin-like growth factor signaling pathways. As a peptide compound, it serves as a valuable molecular tool for dissecting the functional domains of IRS-2, which is integral to cellular responses such as glucose metabolism, growth, and differentiation. Its defined sequence enables researchers to investigate site-specific interactions, post-translational modifications, and the mechanistic underpinnings of insulin signaling cascades in various biological contexts. The use of this peptide fragment supports advanced studies in metabolic regulation, signal transduction, and the molecular basis of insulin resistance.

Signal transduction studies: Researchers frequently utilize this IRS-2-derived peptide to probe the molecular mechanisms of insulin receptor signaling. By mimicking a specific region of the full-length protein, the peptide enables detailed mapping of phosphorylation sites and interaction motifs that mediate downstream signaling events. Such investigations are pivotal for elucidating how IRS-2 transmits signals from activated insulin receptors to intracellular effector proteins, thereby advancing the understanding of metabolic regulation at the molecular level.

Kinase substrate assays: The peptide fragment is widely employed as a substrate in kinase activity assays, particularly for tyrosine kinases such as the insulin receptor. Its defined amino acid sequence allows for precise assessment of kinase specificity, activity, and regulatory mechanisms in vitro. By quantifying phosphorylation events on this peptide, scientists can evaluate the functional consequences of mutations, inhibitors, or activators on the enzymatic activity of insulin receptor kinases, supporting both basic research and early-stage drug discovery efforts.

Protein-protein interaction analysis: The IRS-2 (989-1007) peptide serves as a useful probe for identifying and characterizing binding partners that interact with this region of the parent protein. Through techniques such as pull-down assays, surface plasmon resonance, or fluorescence polarization, researchers can assess the affinity and specificity of interactions between IRS-2 and adaptor proteins, phosphatases, or other signaling molecules. These studies contribute to a more comprehensive understanding of the dynamic protein networks that regulate insulin action and cellular homeostasis.

Antibody production and epitope mapping: The defined sequence of this peptide fragment makes it suitable for generating sequence-specific antibodies or for mapping antigenic epitopes within the IRS-2 protein. Polyclonal or monoclonal antibodies raised against this region can be employed in immunoprecipitation, immunoblotting, or immunofluorescence applications to track IRS-2 localization, expression, or post-translational modifications in cell and tissue samples. Such reagents are essential for dissecting IRS-2 function and for validating experimental models of metabolic signaling.

Peptide-based inhibitor design: The structural and functional information provided by the IRS-2 (989-1007) peptide facilitates the rational design of peptide-based inhibitors or mimetics targeting protein-protein interactions within insulin signaling pathways. By serving as a template for structure-activity relationship studies, the peptide aids in the development of novel molecular tools or lead compounds that selectively modulate IRS-2-mediated signaling events. This approach supports both mechanistic research and the exploration of potential strategies for modulating insulin sensitivity in metabolic research models.

Source#
Homo sapiens (human)
Epitope
989-1007
Restricting HLA
HLA-A2
References
Kwasi Antwi; Mol Immunol 2009

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Epitope Mapping ServicesPeptide Nucleic Acids SynthesiscGMP Peptide ServiceCustom Conjugation ServicePeptide Analysis ServicesPeptide Synthesis ServicesPeptide CDMOPeptide Modification Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers

Creative Peptides customer logo 1 Creative Peptides customer logo 2 Creative Peptides customer logo 3 Creative Peptides customer logo 4 Creative Peptides customer logo 5 Creative Peptides customer logo 6 Creative Peptides customer logo 7 Creative Peptides customer logo 8 Creative Peptides customer logo 9 Creative Peptides customer logo 10 Creative Peptides customer logo 11 Creative Peptides customer logo 12 Creative Peptides customer logo 13 Creative Peptides customer logo 14 Creative Peptides customer logo 15 Creative Peptides customer logo 16 Creative Peptides customer logo 17 Creative Peptides customer logo 18 Creative Peptides customer logo 19 Creative Peptides customer logo 20 Creative Peptides customer logo 21 Creative Peptides customer logo 22 Creative Peptides customer logo 23 Creative Peptides customer logo 24 Creative Peptides client partner 1 Creative Peptides client partner 2 Creative Peptides client partner 3 Creative Peptides client partner 4 Creative Peptides client partner 5 Creative Peptides client partner 6 Creative Peptides client partner 7 Creative Peptides client partner 8 Creative Peptides client partner 9 Creative Peptides client partner 10 Creative Peptides client partner 11 Creative Peptides client partner 12 Creative Peptides client partner 13 Creative Peptides client partner 14 Creative Peptides client partner 15 Creative Peptides client partner 16 Creative Peptides client partner 17 Creative Peptides client partner 18 Creative Peptides client partner 19 Creative Peptides client partner 20 Creative Peptides client partner 21 Creative Peptides client partner 22 Creative Peptides client partner 23 Creative Peptides client partner 24